Inam Butt and the Late TUE Letter: When an Asian Beach Games Silver Medal Is Placed on the Legal Scale

Last April, at the Asian Beach Games, Inam Butt stepped onto the podium to collect a silver medal with the posture of a man long accustomed to big stages. He is a former beach wrestling world champion - a still-young UWW discipline, but enough to frame a Pakistani grappler's name as a benchmark. Four months later, what grabs public attention in his country is no longer a takedown or an escape, but a letter from the International Testing Agency (ITA), the independent anti-doping body of the Olympic movement. The letter concerns an eye drop. And that alone is enough to place April's silver medal on a different scale: the legal one.

Read only the headline, and one might assume this is a routine doping case. But according to what Pakistani media has reported, the story runs on an entirely different axis. The ITA accepted that the medication Inam used was for an eye condition - a genuine medical issue, not a performance enhancer. The fault lay in procedure: he failed to obtain a Therapeutic Use Exemption (TUE) in time. Under WADA's anti-doping rules, missing a signature by a deadline still counts as a violation - even when the pill inside the bottle is medically legitimate.

That is the starting point for everything that follows. Data does not betray us; we simply place our trust in the wrong place.

Context a Vietnamese reader needs before passing judgment: the Olympic anti-doping system does not run on the logic of "if you're sick, you may take medicine." It runs on the logic of "if you're sick, you must declare in advance." An athlete with asthma, diabetes, or in this case an eye condition, has every right to take treatment. But to do so legally, he must file a TUE and wait for approval - sometimes weeks. If the moment he needs the drug collides with competition, the delay can turn a patient into a violation case.

Inam Butt is no rookie. He is a former beach wrestling world champion, and currently serves as a national squad coach for Pakistan. On top of that, he is secretary of the Pakistan Wrestling Federation (PWF) and chairman of the Pakistan Olympic Association (POA) Athletes Commission. Three roles in one person. In a sport with a thin talent pool, that concentration is not unusual - but it is also why this case is more complicated than an ordinary doping file.

Because when the news broke, Inam was not merely an athlete under investigation. He also sat inside the governing machinery of the very sport he competed in. A man who is both suspect and administrator - that is the classic conflict-of-interest structure smaller federations often stumble into. And the way Inam handled it shows he understood: he voluntarily stepped down from his PWF secretary post and his POA Athletes Commission chairmanship, citing the need to protect the impartiality of the investigation.

That move is purely governance hygiene. It is neither evidence of guilt nor evidence of innocence. It is simply how an experienced man chooses to step aside while a system needs to be seen as clean.

The crux lies in how the ITA is handling the file, and in the numbers on the timeline. According to cited sources, the ITA is expected to issue a formal ruling within a week. The anticipated sanction is roughly a two-month suspension, backdated to April - when the Asian Beach Games took place, and when the sample was collected. That backdating is no small detail. It signals that the adjudicating body is applying the "no significant fault or negligence" bracket under the WADA Code, rather than the "significant fault" bracket.

In other words, two months is the punishment for someone who forgot to file paperwork, not for a cheat.

There is another wrinkle in the account worth flagging: at the same time, one report says Inam failed to obtain a TUE in time, while another says the ITA granted him permission to use the medication for a one-year period. Those two propositions can only be reconciled if the permit was granted retroactively, or applied to a different drug within the same eye-treatment protocol. That contradiction has not been clarified in the source. And as a working journalist, I have to say it plainly: when key claims rest on unnamed sources, they hold only until the formal ruling is published.

This is precisely where pure technical analysis runs dry. In a wrestling piece, we talk about stance, finishing ability, opponent quality. But here there is no opponent. The only matchup in this story is between a medical explanation and the strict liability standard of anti-doping law, with the ITA as arbiter.

And here is the counterintuitive point I want to put on the table: what Inam loses is not the two-month suspension, but the silver medal. Under WADA's strict liability principle, medal forfeiture does not depend on whether the drug was therapeutic. Once a prohibited substance appears in a urine sample, the result of that competition is automatically voided, regardless of the athlete's intent. That explains why, even if the medication is judged legitimate, Inam will most likely still lose April's silver.

Two months can pass quickly. An international silver medal stays in the record permanently.

Physically and career-wise, Inam's actual risk level is assessed as moderate. He is no longer at peak form - coaching and administrative roles indicate he has entered a transitional phase. The eye condition is a health-and-eligibility variable, not a performance variable. But because it may be chronic, the possibility of it becoming a prolonged issue is real. From now on, every TUE filing he makes will be an expensive reminder.

What interests me more is the governance layer. This case exposes a pattern easily recognized in smaller sports federations: a thin talent pool forces one individual to simultaneously serve as athlete, coach, and administrator. When that person is drawn into a dispute, the entire apparatus ends up handling a scandal instead of the sport. Inam's voluntary withdrawal from the PWF secretary role and the POA Athletes Commission chairmanship was a necessary move, but it also leaves two positions vacant for at least a few weeks. For a small federation, that is no small matter.

So the question worth asking is not whether Inam Butt is guilty - the system has already quietly answered - but: what makes an experienced athlete, once at the top of the world, miss such a basic procedure? The answer lies in the gap between medicine and the rulebook. A doctor can write a prescription at any time. But a TUE must pass through an administrative system - and that system is not as fast as an aching eye.

In this frame, a two-month suspension and a stripped medal cease to be a personal story. They become an administrative lesson for the whole region. For federations in South Asia and Southeast Asia - where many athletes compete semi-professionally and handle their own medical paperwork - the skill of filing a TUE on time is not in any training plan, yet it can decide an entire career. That is a training gap every sports ecosystem carries; Inam Butt is simply the one who paid first.

On the ITA's side, the fact that an independent body rather than a national federation is handling the file is itself a noteworthy signal. When adjudication authority sits outside national influence, outcomes tend to bend less under domestic pressure. In a case touching the name of an athlete once regarded as a national pride, letting the ITA hold the scale is the only way a ruling can be seen as fair - whatever the result.

Back to the point raised at the top: the ruling is expected within days. That is the moment that could confirm or destroy Inam's chances of competing at the upcoming Asian Games. If a two-month penalty is applied and backdated to April, he is fully eligible for the Asian Games - one of the key stages of his coaching and competitive career. If the penalty is pushed heavier, that door closes.

I do not know what the final ruling will be, and I do not want to guess before it is published. But one thing I know for certain: when a world champion loses a medal over an eye drop rather than a performance drug, the problem is not with that athlete - it is with how we taught him the rules of the game.

Against the backlight, you still see clearly - that is when you are standing in the right spot. The only question left is whether Inam Butt is standing in that right spot, and whether that late TUE envelope can be cleared in the eyes of Pakistani public opinion in time.